Opinion|Videos|December 7, 2023
A Patient’s Experience With an RCC Diagnosis
Author(s)Thomas E. Hutson, DO, PharmD, Kacie Ellis, RN
Mr. Cesar Fuentes had a kidney tumor surgically removed; lymph node and bone metastases years later led to immune and targeted therapy which have provided significant tumor shrinkage and generally mild, manageable side effects.
Advertisement
Episodes in this series
Advertisement
Related to this article
“What we are trying to do more often is to ablate as much as we can,” said Shankar Siva, MBBS, PhD, FRANZCR, on pairing SABR with systemic therapy in RCC.
Advertisement
Advertisement
Trending on CancerNetwork
1
AI-Measured Tumor Volume on PSMA PET-CT Linked With Survival in Prostate Cancer
2
How Could Rocbrutinib Plus R-CHOP Reshape Frontline Non-GCB DLBCL Treatment?
3
Managing FLOT Toxicity With Dose Reductions in Gastroesophageal Cancer
4
Expanding Access to Advanced Radiation Services Across a Network
5